Results 301 to 310 of about 1,502,313 (400)

Gene expression in vitro of colicin E1 plasmid

, 1979
Yousuke Ebina, Fumio Kishi, Teruko Nakazawa, Atsushi Nakazawa   +3 more
openalex   +2 more sources

Multivalent Protein Nanorings for Broad and Potent SARS‐CoV‐2 Neutralization

Advanced Healthcare Materials, EarlyView.
A protein‐only, modular multivalent nanoscaffold displaying 20 anchor points, decorated with two different binders (10 of each), targeting the SARS‐CoV‐2 receptor‐binding domain is presented. The construct self‐assembles into stable, biocompatible, homogeneous nanoparticles, exhibit synergistic binding with fM IC50 values. It also detects spike at 9 ng 
Molood Behbahanipour, Carla Goldin, Cecilia Arahi Prato, Ana Luz Paletta, Oriol Bárcenas, Susanna Navarro, Jordi Pujols, Daniel H. Murgida, María Virginia Tribulatti, Sebastián Esperante, Damian Alvarez‐Paggi, Salvador Ventura   +11 more
wiley   +1 more source

<i>Klebsiella pneumoniae</i> with Two Carbapenemases: Where Molecular Research Stands Now. [PDF]

Infect Drug Resist
Yu Q, Li G, Xu Q, Zhu Y.
europepmc   +1 more source

Spontaneous formation of cointegrates of the oncogenic Ti-Plasmid and the wide-host-range P-plasmid RP4

, 1978
M. Holsters, B. Silva, C. Genetello, Gilbert Engler, F. Van Vliet, Marc De Block, Raimundo Villarroel, M. Van Montagu, Jeff Schell   +8 more
openalex   +2 more sources

Molecular Simulations of Polymer‐based Drug Nanocarriers: From Physical and Structural Properties to Controlled Release

Advanced Healthcare Materials, EarlyView.
Polymer‐based drug delivery systems can effectively overcome the limitations of free drugs in terms of solubility, stability, and plasma half‐life, yet their development has traditionally relied on time‐consuming trial‐and‐error approaches. This review highlights recent advances in applying molecular simulation to the design of polymer‐based drug ...
Ping Gao, Xin Jiang, Jinyu Li, Julien Nicolas, Tâp Ha‐Duong   +4 more
wiley   +1 more source

Advances in molecular adjuvants for nucleic acid vaccines. [PDF]

Front Immunol
Hojecki CE, Tursi NJ, Livingston C, Weiner DB, Gary EN.   +4 more
europepmc   +1 more source

Living Materials Approach for In Situ Bio‐Polymers Production Using Bacillus Paralicheniformis in Microneedles

Advanced Healthcare Materials, EarlyView.
Dissolvable microneedle (MN) device containing Bacillus paralicheniformis. The polymeric matrix encapsulates and protects the bacteria, preserving their viability while enabling in situ production and release of γ‐polyglutamic acid. The bacteria are delivered into the skin via 500 µm‐long microneedles, and remain detectable on the skin 24 h post ...
Caroline Hali Alperovitz, Noa Ben David, Adi Gross, Boaz Mizrahi   +3 more
wiley   +1 more source

Identification of Plasma-Generated Reactive Species in Water and Their DNA-Damaging Effects on Plasmid and Lymphocyte DNA. [PDF]

Int J Mol Sci
Kyzek S, Pišteková S, Kyzeková I, Ševčovičová A, Kováčik D, Zahoranová A, Gálová E.   +6 more
europepmc   +1 more source

Plug‐and‐Play Centrifuge‐Only Device for Rapid Sepsis Diagnosis

Advanced Healthcare Materials, EarlyView.
A fully automated, centrifuge‐only device can isolate and concentrate bacteria from blood for rapid sepsis diagnosis. The device enables >3×$>3\times$ bacterial enrichment and removes >$>$99.9% of blood cells. The device supports direct downstream analysis via subculturing, MALDI‐TOF, and microfluidic detection of bacteria.
Mohammad Osaid, M. Henar Marino Miguélez, Berke Bayrak, Büsra Betül Özmen‐Capin, Volkan Özenci, Wouter van der Wijngaart   +5 more
wiley   +1 more source

Scarless gene disruption enabled by a dual-plasmid knockout platform in a clinical infant-derived <i>Bifidobacterium breve</i> strain. [PDF]

Front Microbiol
Gao Z, Feng L.
europepmc   +1 more source